DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting

NCT00741065 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Reduced Left Ventricular Function Defined as LVEF < 50%
Regional Left Ventricular Wall Motion Abnormalities

Interventions

PROCEDURE: Direct Epicardial Shock Wave Therapy

Sponsor

Cardiac Regeneration Technologies, LLC